Eric Kalo retweeted
Peptide user tore oesophagus after using counterfeit product, Australian regulator warns. theguardian.com/australia-ne…
Ozempic is in the headlines. Berberine is called "nature's Ozempic." But what's the evidence for MASLD?
Our new paper explores the science behind the hype.
▶️doi.org/10.1002/prp2.70300
#MASLD #Ozempic #Berberine
23
Eric Kalo retweeted
📜 NITs in defining CSPH — Baveno VIII
🗣️ @RodriguesSu24 | #EASLCongress
Key messages:
🔬 LSM + ANTICIPATE → mainstay of CSPH diagnosis ⚠️ Repeat NITs every 12 m — most recent value wins
💡 SSM + biomarkers reduce the CSPH grey zone
🚀 Future: AI-driven multimodal assessment
Eric Kalo retweeted
📜 From cirrhosis to cACLD through modern diagnostics
🗣️ J. Génesca & P. Hytiroglou
Key messages:
🔬 NITs reshaped cACLD — but pathology is NOT dead! ⚠️ Up to 37% with LSM ≥13 kPa have occult cACLD
💡 Clinicopathologic correlation remains key
#EASLCongress
doi.org/10.1111/jgh.70453
Comment on “Mediterranean Diet Adherence Is Associated With Reduced Liver Fibrosis Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease”
18
Eric Kalo retweeted
Combined therapy with ixekizumab and tirzepatide led to higher rates of complete skin clearance and ≥10% weight reduction at 36 weeks in adults with moderate to severe #Psoriasis and #overweight or #obesity.
ja.ma/3PEpFkz
🇦🇺 New best practice recommendations for TIPS in portal hypertension are out! A comprehensive consensus statement for clinicians.
▶️doi.org/10.1007/s12072-025-1…
#Hepatology #TIPS #PortalHypertension #Guidelines
@GESAorg @jcu @westernsydneyu @IRSA_IRs
1
50
This statement is a result of collaboration between the Gastroenterological Society of Australia (GESA) and the Interventional Radiology Society of Australasia (IRSA), with contributions from more than 50 experts.
@WestSydHealth
@westsydunews
@hepinternation1
@DrTaraLRoberts
25
Eric Kalo retweeted
Glucagon-like peptide 1 receptor agonists (GLP-1RAs):
👉GLP-1 is a peptide hormone released from the distal ileum & colon after oral nutrient intake.
👉GLP-1RA reduces glucose by increasing glucose-dependent insulin secretion from beta cells in the pancreas, by decreasing glucagon secretion, as well as by delaying gastric emptying, which leads to satiety.
👉Beneficial effects on important determinants of CV risk, including weight loss, blood pressure, & triglyceride reduction as well as anti-inflammatory effects.
dharsaty.com
Eric Kalo retweeted
A one-shot gene therapy to make a lifetime's worth of GLP-1 (like Ozempic) @FractylHealth. But it requires direct injection to the pancreas and there are lots of unknowns. A clinical trial is starting soon.
Front page @washingtonpost today
gift link washingtonpost.com/health/20…
Eric Kalo retweeted
Natural daylight and improved glucose control in Type 2 diabetes
cell.com/cell-metabolism/ful… @Cell_Metabolism
Eric Kalo retweeted
The other great randomized trial of coffee drinking is this one
Those in the coffee group had similar rates of premature atrial contractions (though slightly more premature ventricular contractions)
Coffee drinkers also slept less, and did about 1,000 extra steps per day!
📊 Research Summary: Adults with #AFib who drank at least one cup of caffeinated coffee daily after successful cardioversion had a lower risk of recurrence than those who abstained from coffee and caffeine.
#AHA25
ja.ma/3WKyFVq
Eric Kalo retweeted
📖 New review in Livers:
Liver cirrhosis care is evolving with advances in imaging, biomarkers, therapies & precision medicine. A paradigm shift toward multimodal & personalized management.
🔗 mdpi.com/2673-4389/4/2/18
#LiverCirrhosis #Hepatology #LiverDisease
Eric Kalo retweeted
Liver testing goes prime time
nejm.org/doi/full/10.1056/NE…
Eric Kalo retweeted
APASL has just released its new guidelines on the management of acute variceal bleeding, led by Prof. @drshivsarin with Dr. @CosmasLesmana and Dr. @drakashshukla3 as the leading authors. I’m grateful to have been included as a co-author along with colleagues from across Asia-Pacific. These @APASLnews guidelines are published in @hepinternation1
Read full guidelines: link.springer.com/article/10…
In this thread 🧵, we share the highlights ⬇️
Eric Kalo retweeted
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide.
In @LancetGastroHep, a new Personal View proposes a comprehensive and multisectoral approach for the sustainable management of MASLD: hubs.li/Q03GbF340
Eric Kalo retweeted
AASLD AST Practice Guideline on Adult Liver Transplantation: Diagnosis and management of Graft-Related complications
journals.lww.com/lt/abstract…
Eric Kalo retweeted
Happy International Women’s Day!
We’re celebrating women who have changed the world. Here are all of the amazing women who have received the #NobelPrize and their remarkable achievements at the time of the award.
Tell us about the women who inspire you the most - and why
#InternationalWomensDay
Eric Kalo retweeted
The global burden of liver cancer is increasing, with new cases set to double by 2050.
On the cover, the latest Commission report on addressing the global hepatocellular carcinoma burden.
This and more in our latest issue 👉 hubs.li/Q03CWycG0

































